Australia markets open in 5 hours 18 minutes

Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
11.80-0.13 (-1.09%)
At close: 03:00PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
855,130
816,765
764,547
569,698
409,249
Cost of revenue
384,742
367,151
370,795
257,575
178,295
Gross profit
470,388
449,614
393,753
312,123
230,954
Operating expenses
Research development
79,846
78,058
67,073
68,825
50,770
Selling general and administrative
71,722
70,244
60,531
40,916
33,938
Total operating expenses
188,160
187,552
179,664
152,630
110,321
Operating income or loss
282,228
262,062
214,089
159,493
120,632
Interest expense
7,581
7,995
6,107
1,466
1,384
Income before tax
311,770
290,762
255,859
159,391
95,498
Income tax expense
39,060
36,860
20,483
13,461
8,662
Income from continuing operations
272,710
253,902
235,376
145,930
86,836
Net income
272,710
253,902
235,376
145,930
86,836
Net income available to common shareholders
272,710
253,902
235,376
145,930
86,836
Basic EPS
0.49
0.43
0.41
0.26
0.16
Diluted EPS
0.49
0.43
0.41
0.26
0.16
Basic average shares
574,851
590,470
574,087
567,506
531,871
Diluted average shares
574,851
590,470
574,087
567,506
531,871